Le Lézard
Classified in: Health
Subject: PER

PaxeraHealth Announces New VP Sales & Chief Technology Officer Arrivals


BOSTON, April 23, 2018 /PRNewswire/ -- PaxeraHealth is pleased to welcome Warner (Chuck) Pyne III and Paul Dandrow into its leadership team.

PaxeraHealth, PACS, PACS solutions, enterprise imaging

Pyne joins PaxeraHealth as the Vice President of Sales for the U.S. market. He's a 35-year medical imaging industry veteran, previously working for Philips Medical Systems (for PACS) and Dynamic Imaging (acquired by GE Medical Systems). During his career, he's also held multiple positions in sales and operations for Fuji Medical Systems. Most recently, he was the National Sales Specialist for NTT DATA Services' Enterprise Imaging and Analytics portfolio.

"I have been fortunate to see this industry from several perspectives and have seen  impressive technologies emerge during my career," Pyne said. "Seeing PaxeraHealth's technology, approach to the financial challenges our customers face, and their commitment to customer satisfaction, I'm very pleased to be part of this team and see a bright future for the company and organizations who elect to partner with us."

As an information technology executive with more than 25 years' experience in sales and sales delivery, Paul Dandrow comes on board as the Chief Technology Officer. Professionally, he's been instrumental in growth from start-ups to Fortune 60 businesses. Dandrow has held a number of business development positions with InSiteOne Inc. (business, marketing, and sales team management) and Superior Consultant Co. (business strategy). Most recently, he was the Global Delivery Director for NTT DATA/Dell Services, creating the company's healthcare cloud.

"When I started looking for my next 'adventure,' I knew what I wanted ? a company that had leading-edge software, a global customer base thrilled with its performance, and a strong, dedicated, passionate technical team. It had to be small enough so I could make a difference, but big enough that they had the resources to develop and deliver next-generation enterprise imaging services," Dandrow said. "I assumed I would be fortunate to find a company with three of those characteristics. I was wrong ? with PaxeraHealth, I found a company with all five."

We eagerly anticipate and welcome their contributions as PaxeraHealth continues its growth as an innovative medical imaging solution developer.

About PaxeraHealth

PaxeraHealth Corptm, formerly Paxeramed, is a world leading medical imaging solution developer based in Boston, Mass. The company, with top priorities of leveraging technology and staying at the new imaging technology forefront, develops next generation medical imaging technologies, including Enterprise imaging and VNAs designed to automate clients' workflow, elevate patient care, and cut departmental imaging costs.

Company contacts: 
PaxeraHealth Corp. 
300 Washington St, Newton, MA. 02458  
[email protected]  
www.paxerahealth.com 
1 888 430 0005

Mike George 
617 607 3435

SOURCE PaxeraHealth


These press releases may also interest you

at 16:40
Pfizer Inc. today announced that its board of directors declared a $0.42 second-quarter 2024 dividend on the company's common stock, payable June 14, 2024, to holders of the Common Stock of record at the close of business on May 10, 2024. The...

at 16:35
Ecolab will host a live webcast of its annual meeting of stockholders. As indicated in our proxy statement, the 2024 Annual Meeting of Stockholders will be a virtual-only meeting. Details for the public webcast are as follows: TIME:...

at 16:35
Summit Therapeutics Inc. ("Summit," "we," or the "Company") will host an earnings call to announce its first quarter 2024 financial results and provide an operational update for the Company on Wednesday, May 1, 2024, before the market opens....

at 16:35
Hapbee Technologies, Inc. ("Hapbee" or the "Company"), the digital wellness technology company is pleased to confirm that it has completed a non-brokered private placement of units of the Company ("Units") for aggregate gross proceeds to the...

at 16:30
Collaboration on TSMC's COUPE silicon photonics platform dramatically speeds chip-to-chip and machine-to-machine communication for cloud, datacenters, HPC, and AI chips / Key Highlights Ansys and TSMC deliver a high-fidelity multiphysics solution to...

at 16:30
The Board of Directors of The Cigna Group today declared a cash dividend of $1.40 per share of its common stock, payable on June 20, 2024 to shareholders of record as of the close of business on June 4, 2024....



News published on and distributed by: